Status:
COMPLETED
Racial Differences: Nitric Oxide(NO) and Endothelin-1(ET-1) in Preeclampsia (PreE)
Lead Sponsor:
University of Mississippi Medical Center
Collaborating Sponsors:
Office of Minority Health
Mississippi Institute for Improvement of Geographic Minority Health
Conditions:
Preeclampsia
Eligibility:
FEMALE
18-40 years
Brief Summary
The goal of this study is to examine the activation of markers of endothelial and cardiovascular dysfunctions, from women with high-risk pregnancies. Information from this study will hopefully provide...
Eligibility Criteria
Inclusion
- African-american or Caucasian
- Pregnant
- Between ages of 18 - 40 years of age
Exclusion
- Presence of a disease or condition which is not preeclampsia
- Drug or alcohol abuse during pregnancy
- Obesity
Key Trial Info
Start Date :
June 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT00653809
Start Date
June 1 2007
End Date
September 1 2009
Last Update
April 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of MS Medical Center
Jackson, Mississippi, United States, 39216